A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT04419649 · RECRUITING
Trial details
- NCT number
- NCT04419649
- Sponsor
- Takeda
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2029-10-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.